世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

世界および中国における細胞移植の市場規模、現状、予測2021-2027年


Global and China Cell Transplant Market Size, Status and Forecast 2021-2027

細胞移植とは、幹細胞や多能性幹細胞に誘導された細胞を、組織が損傷したり病気になったりしている部位に移植する方法である。移植は、個人内(自家移植)、個人間、または種間で行われる。 市場分析とインサ... もっと見る

 

 

出版社 出版年月 電子版価格 言語
QYResearch
QYリサーチ
2021年11月5日 US$3,900
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

サマリー

細胞移植とは、幹細胞や多能性幹細胞に誘導された細胞を、組織が損傷したり病気になったりしている部位に移植する方法である。移植は、個人内(自家移植)、個人間、または種間で行われる。

市場分析とインサイト細胞移植の世界市場
細胞移植の世界市場規模は、2020年のXX百万米ドルから、2021-2027年の間にXX%のCAGRで、2027年にはXX百万米ドルに達すると予測されます。
本レポートは、業界標準の正確な分析と高いデータの整合性により、世界の細胞移植市場で得られる主要な機会を明らかにし、プレイヤーが市場での確固たる地位を獲得するのに役立つことを目的としています。本レポートの購入者は、検証された信頼性の高い市場予測にアクセスすることができ、その中には、収益面での世界の細胞移植市場全体のサイズに関する予測も含まれています。
本レポートは、プレイヤーが競合他社に対して優位に立ち、世界の細胞移植市場で永続的な成功を収めるための効果的なツールであることを証明しています。本レポートに掲載されているすべての調査結果、データ、情報は、信頼できる情報源の助けを借りて検証、再検証されています。本レポートを執筆したアナリストは、世界の細胞移植市場を詳細に調査するために、独自の業界最高の調査・分析手法を用いています。

世界の細胞移植の範囲と市場規模
細胞移植市場は、企業別、地域(国)別、タイプ別、アプリケーション別に分類されています。世界の細胞移植市場に参加するプレイヤー、ステークホルダー、その他の参加者は、このレポートを強力なリソースとして利用することで、優位に立つことができるでしょう。セグメント別分析では、2016年から2027年の期間におけるタイプ別、アプリケーション別の収益と予測に焦点を当てています。

タイプ別セグメント
末梢血幹細胞移植(PBSCT)
骨髄移植(BMT)
臍帯血移植(CBT)

用途別セグメント
病院
クリニック
その他

地域別
北アメリカ
米国
カナダ
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
ロシア
北欧
その他のヨーロッパ諸国
アジア太平洋地域
中国
日本
韓国
東南アジア
インド
オーストラリア
その他のアジア諸国
ラテンアメリカ
メキシコ
ブラジル
その他のラテンアメリカ
中近東・アフリカ
トルコ
サウジアラビア
アラブ首長国連邦
その他の中東・アフリカ地域

会社別
Regen Biopharma
グローバルコードブラッド社
CBRシステムズ
エスケープ・セラピューティクス
クライオセーブ
ロンザグループ
プルリステム・セラピューティクス
ステメダカセルテクノロジー


ページTOPに戻る


目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cell Transplant Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Peripheral Blood Stem Cells Transplant (PBSCT)
1.2.3 Bone Marrow Transplant (BMT)
1.2.4 Cord Blood Transplant (CBT)
1.3 Market by Application
1.3.1 Global Cell Transplant Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Cell Transplant Market Perspective (2016-2027)
2.2 Cell Transplant Growth Trends by Regions
2.2.1 Cell Transplant Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Cell Transplant Historic Market Share by Regions (2016-2021)
2.2.3 Cell Transplant Forecasted Market Size by Regions (2022-2027)
2.3 Cell Transplant Industry Dynamic
2.3.1 Cell Transplant Market Trends
2.3.2 Cell Transplant Market Drivers
2.3.3 Cell Transplant Market Challenges
2.3.4 Cell Transplant Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Cell Transplant Players by Revenue
3.1.1 Global Top Cell Transplant Players by Revenue (2016-2021)
3.1.2 Global Cell Transplant Revenue Market Share by Players (2016-2021)
3.2 Global Cell Transplant Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Cell Transplant Revenue
3.4 Global Cell Transplant Market Concentration Ratio
3.4.1 Global Cell Transplant Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell Transplant Revenue in 2020
3.5 Cell Transplant Key Players Head office and Area Served
3.6 Key Players Cell Transplant Product Solution and Service
3.7 Date of Enter into Cell Transplant Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Cell Transplant Breakdown Data by Type
4.1 Global Cell Transplant Historic Market Size by Type (2016-2021)
4.2 Global Cell Transplant Forecasted Market Size by Type (2022-2027)

5 Cell Transplant Breakdown Data by Application
5.1 Global Cell Transplant Historic Market Size by Application (2016-2021)
5.2 Global Cell Transplant Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Cell Transplant Market Size (2016-2027)
6.2 North America Cell Transplant Market Size by Type
6.2.1 North America Cell Transplant Market Size by Type (2016-2021)
6.2.2 North America Cell Transplant Market Size by Type (2022-2027)
6.2.3 North America Cell Transplant Market Size by Type (2016-2027)
6.3 North America Cell Transplant Market Size by Application
6.3.1 North America Cell Transplant Market Size by Application (2016-2021)
6.3.2 North America Cell Transplant Market Size by Application (2022-2027)
6.3.3 North America Cell Transplant Market Size by Application (2016-2027)
6.4 North America Cell Transplant Market Size by Country
6.4.1 North America Cell Transplant Market Size by Country (2016-2021)
6.4.2 North America Cell Transplant Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Cell Transplant Market Size (2016-2027)
7.2 Europe Cell Transplant Market Size by Type
7.2.1 Europe Cell Transplant Market Size by Type (2016-2021)
7.2.2 Europe Cell Transplant Market Size by Type (2022-2027)
7.2.3 Europe Cell Transplant Market Size by Type (2016-2027)
7.3 Europe Cell Transplant Market Size by Application
7.3.1 Europe Cell Transplant Market Size by Application (2016-2021)
7.3.2 Europe Cell Transplant Market Size by Application (2022-2027)
7.3.3 Europe Cell Transplant Market Size by Application (2016-2027)
7.4 Europe Cell Transplant Market Size by Country
7.4.1 Europe Cell Transplant Market Size by Country (2016-2021)
7.4.2 Europe Cell Transplant Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Cell Transplant Market Size (2016-2027)
8.2 Asia-Pacific Cell Transplant Market Size by Type
8.2.1 Asia-Pacific Cell Transplant Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Cell Transplant Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Cell Transplant Market Size by Type (2016-2027)
8.3 Asia-Pacific Cell Transplant Market Size by Application
8.3.1 Asia-Pacific Cell Transplant Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Cell Transplant Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Cell Transplant Market Size by Application (2016-2027)
8.4 Asia-Pacific Cell Transplant Market Size by Region
8.4.1 Asia-Pacific Cell Transplant Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Cell Transplant Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Cell Transplant Market Size (2016-2027)
9.2 Latin America Cell Transplant Market Size by Type
9.2.1 Latin America Cell Transplant Market Size by Type (2016-2021)
9.2.2 Latin America Cell Transplant Market Size by Type (2022-2027)
9.2.3 Latin America Cell Transplant Market Size by Type (2016-2027)
9.3 Latin America Cell Transplant Market Size by Application
9.3.1 Latin America Cell Transplant Market Size by Application (2016-2021)
9.3.2 Latin America Cell Transplant Market Size by Application (2022-2027)
9.3.3 Latin America Cell Transplant Market Size by Application (2016-2027)
9.4 Latin America Cell Transplant Market Size by Country
9.4.1 Latin America Cell Transplant Market Size by Country (2016-2021)
9.4.2 Latin America Cell Transplant Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Cell Transplant Market Size (2016-2027)
10.2 Middle East & Africa Cell Transplant Market Size by Type
10.2.1 Middle East & Africa Cell Transplant Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Cell Transplant Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Cell Transplant Market Size by Type (2016-2027)
10.3 Middle East & Africa Cell Transplant Market Size by Application
10.3.1 Middle East & Africa Cell Transplant Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Cell Transplant Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Cell Transplant Market Size by Application (2016-2027)
10.4 Middle East & Africa Cell Transplant Market Size by Country
10.4.1 Middle East & Africa Cell Transplant Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Cell Transplant Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Regen Biopharma
11.1.1 Regen Biopharma Company Details
11.1.2 Regen Biopharma Business Overview
11.1.3 Regen Biopharma Cell Transplant Introduction
11.1.4 Regen Biopharma Revenue in Cell Transplant Business (2016-2021)
11.1.5 Regen Biopharma Recent Development
11.2 Global Cord Blood Corporation
11.2.1 Global Cord Blood Corporation Company Details
11.2.2 Global Cord Blood Corporation Business Overview
11.2.3 Global Cord Blood Corporation Cell Transplant Introduction
11.2.4 Global Cord Blood Corporation Revenue in Cell Transplant Business (2016-2021)
11.2.5 Global Cord Blood Corporation Recent Development
11.3 CBR Systems
11.3.1 CBR Systems Company Details
11.3.2 CBR Systems Business Overview
11.3.3 CBR Systems Cell Transplant Introduction
11.3.4 CBR Systems Revenue in Cell Transplant Business (2016-2021)
11.3.5 CBR Systems Recent Development
11.4 Escape Therapeutics
11.4.1 Escape Therapeutics Company Details
11.4.2 Escape Therapeutics Business Overview
11.4.3 Escape Therapeutics Cell Transplant Introduction
11.4.4 Escape Therapeutics Revenue in Cell Transplant Business (2016-2021)
11.4.5 Escape Therapeutics Recent Development
11.5 Cryo-Save
11.5.1 Cryo-Save Company Details
11.5.2 Cryo-Save Business Overview
11.5.3 Cryo-Save Cell Transplant Introduction
11.5.4 Cryo-Save Revenue in Cell Transplant Business (2016-2021)
11.5.5 Cryo-Save Recent Development
11.6 Lonza Group
11.6.1 Lonza Group Company Details
11.6.2 Lonza Group Business Overview
11.6.3 Lonza Group Cell Transplant Introduction
11.6.4 Lonza Group Revenue in Cell Transplant Business (2016-2021)
11.6.5 Lonza Group Recent Development
11.7 Pluristem Therapeutics
11.7.1 Pluristem Therapeutics Company Details
11.7.2 Pluristem Therapeutics Business Overview
11.7.3 Pluristem Therapeutics Cell Transplant Introduction
11.7.4 Pluristem Therapeutics Revenue in Cell Transplant Business (2016-2021)
11.7.5 Pluristem Therapeutics Recent Development
11.8 Stemedica Cell Technology
11.8.1 Stemedica Cell Technology Company Details
11.8.2 Stemedica Cell Technology Business Overview
11.8.3 Stemedica Cell Technology Cell Transplant Introduction
11.8.4 Stemedica Cell Technology Revenue in Cell Transplant Business (2016-2021)
11.8.5 Stemedica Cell Technology Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

 

ページTOPに戻る


 

Summary

Cell Transplant is a procedure in which cells, often stem cells or cells that can be induced to become pluripotent stem cells, are transferred to a site where the tissue is damaged or diseased. The transfer can occur within an individual (autologous transplantation), between individuals, or between species.

Market Analysis and Insights: Global Cell Transplant Market
The global Cell Transplant market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cell Transplant market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cell Transplant market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cell Transplant market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cell Transplant market.

Global Cell Transplant Scope and Market Size
Cell Transplant market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cell Transplant market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Peripheral Blood Stem Cells Transplant (PBSCT)
Bone Marrow Transplant (BMT)
Cord Blood Transplant (CBT)

Segment by Application
Hospitals
Clinics
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Regen Biopharma
Global Cord Blood Corporation
CBR Systems
Escape Therapeutics
Cryo-Save
Lonza Group
Pluristem Therapeutics
Stemedica Cell Technology



ページTOPに戻る


Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cell Transplant Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Peripheral Blood Stem Cells Transplant (PBSCT)
1.2.3 Bone Marrow Transplant (BMT)
1.2.4 Cord Blood Transplant (CBT)
1.3 Market by Application
1.3.1 Global Cell Transplant Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Cell Transplant Market Perspective (2016-2027)
2.2 Cell Transplant Growth Trends by Regions
2.2.1 Cell Transplant Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Cell Transplant Historic Market Share by Regions (2016-2021)
2.2.3 Cell Transplant Forecasted Market Size by Regions (2022-2027)
2.3 Cell Transplant Industry Dynamic
2.3.1 Cell Transplant Market Trends
2.3.2 Cell Transplant Market Drivers
2.3.3 Cell Transplant Market Challenges
2.3.4 Cell Transplant Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Cell Transplant Players by Revenue
3.1.1 Global Top Cell Transplant Players by Revenue (2016-2021)
3.1.2 Global Cell Transplant Revenue Market Share by Players (2016-2021)
3.2 Global Cell Transplant Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Cell Transplant Revenue
3.4 Global Cell Transplant Market Concentration Ratio
3.4.1 Global Cell Transplant Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell Transplant Revenue in 2020
3.5 Cell Transplant Key Players Head office and Area Served
3.6 Key Players Cell Transplant Product Solution and Service
3.7 Date of Enter into Cell Transplant Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Cell Transplant Breakdown Data by Type
4.1 Global Cell Transplant Historic Market Size by Type (2016-2021)
4.2 Global Cell Transplant Forecasted Market Size by Type (2022-2027)

5 Cell Transplant Breakdown Data by Application
5.1 Global Cell Transplant Historic Market Size by Application (2016-2021)
5.2 Global Cell Transplant Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Cell Transplant Market Size (2016-2027)
6.2 North America Cell Transplant Market Size by Type
6.2.1 North America Cell Transplant Market Size by Type (2016-2021)
6.2.2 North America Cell Transplant Market Size by Type (2022-2027)
6.2.3 North America Cell Transplant Market Size by Type (2016-2027)
6.3 North America Cell Transplant Market Size by Application
6.3.1 North America Cell Transplant Market Size by Application (2016-2021)
6.3.2 North America Cell Transplant Market Size by Application (2022-2027)
6.3.3 North America Cell Transplant Market Size by Application (2016-2027)
6.4 North America Cell Transplant Market Size by Country
6.4.1 North America Cell Transplant Market Size by Country (2016-2021)
6.4.2 North America Cell Transplant Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Cell Transplant Market Size (2016-2027)
7.2 Europe Cell Transplant Market Size by Type
7.2.1 Europe Cell Transplant Market Size by Type (2016-2021)
7.2.2 Europe Cell Transplant Market Size by Type (2022-2027)
7.2.3 Europe Cell Transplant Market Size by Type (2016-2027)
7.3 Europe Cell Transplant Market Size by Application
7.3.1 Europe Cell Transplant Market Size by Application (2016-2021)
7.3.2 Europe Cell Transplant Market Size by Application (2022-2027)
7.3.3 Europe Cell Transplant Market Size by Application (2016-2027)
7.4 Europe Cell Transplant Market Size by Country
7.4.1 Europe Cell Transplant Market Size by Country (2016-2021)
7.4.2 Europe Cell Transplant Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Cell Transplant Market Size (2016-2027)
8.2 Asia-Pacific Cell Transplant Market Size by Type
8.2.1 Asia-Pacific Cell Transplant Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Cell Transplant Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Cell Transplant Market Size by Type (2016-2027)
8.3 Asia-Pacific Cell Transplant Market Size by Application
8.3.1 Asia-Pacific Cell Transplant Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Cell Transplant Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Cell Transplant Market Size by Application (2016-2027)
8.4 Asia-Pacific Cell Transplant Market Size by Region
8.4.1 Asia-Pacific Cell Transplant Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Cell Transplant Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Cell Transplant Market Size (2016-2027)
9.2 Latin America Cell Transplant Market Size by Type
9.2.1 Latin America Cell Transplant Market Size by Type (2016-2021)
9.2.2 Latin America Cell Transplant Market Size by Type (2022-2027)
9.2.3 Latin America Cell Transplant Market Size by Type (2016-2027)
9.3 Latin America Cell Transplant Market Size by Application
9.3.1 Latin America Cell Transplant Market Size by Application (2016-2021)
9.3.2 Latin America Cell Transplant Market Size by Application (2022-2027)
9.3.3 Latin America Cell Transplant Market Size by Application (2016-2027)
9.4 Latin America Cell Transplant Market Size by Country
9.4.1 Latin America Cell Transplant Market Size by Country (2016-2021)
9.4.2 Latin America Cell Transplant Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Cell Transplant Market Size (2016-2027)
10.2 Middle East & Africa Cell Transplant Market Size by Type
10.2.1 Middle East & Africa Cell Transplant Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Cell Transplant Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Cell Transplant Market Size by Type (2016-2027)
10.3 Middle East & Africa Cell Transplant Market Size by Application
10.3.1 Middle East & Africa Cell Transplant Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Cell Transplant Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Cell Transplant Market Size by Application (2016-2027)
10.4 Middle East & Africa Cell Transplant Market Size by Country
10.4.1 Middle East & Africa Cell Transplant Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Cell Transplant Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Regen Biopharma
11.1.1 Regen Biopharma Company Details
11.1.2 Regen Biopharma Business Overview
11.1.3 Regen Biopharma Cell Transplant Introduction
11.1.4 Regen Biopharma Revenue in Cell Transplant Business (2016-2021)
11.1.5 Regen Biopharma Recent Development
11.2 Global Cord Blood Corporation
11.2.1 Global Cord Blood Corporation Company Details
11.2.2 Global Cord Blood Corporation Business Overview
11.2.3 Global Cord Blood Corporation Cell Transplant Introduction
11.2.4 Global Cord Blood Corporation Revenue in Cell Transplant Business (2016-2021)
11.2.5 Global Cord Blood Corporation Recent Development
11.3 CBR Systems
11.3.1 CBR Systems Company Details
11.3.2 CBR Systems Business Overview
11.3.3 CBR Systems Cell Transplant Introduction
11.3.4 CBR Systems Revenue in Cell Transplant Business (2016-2021)
11.3.5 CBR Systems Recent Development
11.4 Escape Therapeutics
11.4.1 Escape Therapeutics Company Details
11.4.2 Escape Therapeutics Business Overview
11.4.3 Escape Therapeutics Cell Transplant Introduction
11.4.4 Escape Therapeutics Revenue in Cell Transplant Business (2016-2021)
11.4.5 Escape Therapeutics Recent Development
11.5 Cryo-Save
11.5.1 Cryo-Save Company Details
11.5.2 Cryo-Save Business Overview
11.5.3 Cryo-Save Cell Transplant Introduction
11.5.4 Cryo-Save Revenue in Cell Transplant Business (2016-2021)
11.5.5 Cryo-Save Recent Development
11.6 Lonza Group
11.6.1 Lonza Group Company Details
11.6.2 Lonza Group Business Overview
11.6.3 Lonza Group Cell Transplant Introduction
11.6.4 Lonza Group Revenue in Cell Transplant Business (2016-2021)
11.6.5 Lonza Group Recent Development
11.7 Pluristem Therapeutics
11.7.1 Pluristem Therapeutics Company Details
11.7.2 Pluristem Therapeutics Business Overview
11.7.3 Pluristem Therapeutics Cell Transplant Introduction
11.7.4 Pluristem Therapeutics Revenue in Cell Transplant Business (2016-2021)
11.7.5 Pluristem Therapeutics Recent Development
11.8 Stemedica Cell Technology
11.8.1 Stemedica Cell Technology Company Details
11.8.2 Stemedica Cell Technology Business Overview
11.8.3 Stemedica Cell Technology Cell Transplant Introduction
11.8.4 Stemedica Cell Technology Revenue in Cell Transplant Business (2016-2021)
11.8.5 Stemedica Cell Technology Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります


よくあるご質問


QYResearch社はどのような調査会社ですか?


QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。   QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/12/20 10:28

158.95 円

165.20 円

201.28 円

ページTOPに戻る